Nucleus RadioPharma

ICYMI: We appointed a stacked Scientific Advisory Board to help us drive innovation and excellence in our end-to-end #CDMO services. 👇 ✅ Dr. Jeremie Calais ✅ Dr. Andrei Iagaru ✅ Dr. Luke Nordquist MD FACP ✅ Dr. Martin Pomper, M.D., Ph.D. ✅ Dr. Oliver Sartor ✅ Dr. George Sgouros ✅ Lisa Jenkins VanLuvanee, Ph.D. Learn more about each board member here: https://hubs.ly/Q02HZH3X0 #Radiopharmaceuticals #SAB #Theranostics

Did you miss our webinar last Thursday with Geoff Johnson, MD, PhD and Kathy Spencer-Pike? No worries, you can access the recording here: https://hubs.ly/Q02HDJTs0 Have any questions or thoughts?💡Don’t hesitate to reach out via email or in the comments below. #Radiopharmaceuticals #Pluvicto #Oncology

Did you know that the #clinical use of radiopharmaceuticals dates back more than 80 years? 🤔 Learn about the past, present, and future of radiopharmaceuticals by clicking the link below. https://hubs.ly/Q02GLVCC0 #Radiopharmaceuticals #TargetedRadiotherapies #CancerCare

Mayo Clinic consultant and Chair of the Division of Nuclear Medicine Geoff Johnson, MD, PhD, was recently featured on Tomorrow's Cure podcast where he discussed advancements in targeted nuclear therapy and collaboration efforts with Nucleus RadioPharma to ensure a steady supply of the complex radiopharmaceuticals needed for these new procedures. #innovaiton #radiology #oncology

𝐃𝐨𝐧’𝐭 𝐦𝐢𝐬𝐬 𝐨𝐮𝐫 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐭𝐡𝐢𝐬 𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲 𝐰𝐢𝐭𝐡 Geoff Johnson, MD, PhD and Kathy Spencer-Pike 👉 𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐍𝐨𝐯𝐚𝐫𝐭𝐢𝐬’𝐬 𝐩𝐮𝐫𝐬𝐮𝐢𝐭 𝐨𝐟 𝐚 𝐥𝐚𝐛𝐞𝐥 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐏𝐥𝐮𝐯𝐢𝐜𝐭𝐨 𝐩𝐨𝐬𝐬𝐢𝐛𝐥𝐲 𝐦𝐞𝐚𝐧 𝐟𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝 𝐨𝐟 𝐫𝐚𝐝𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲? Register now: https://hubs.ly/Q02GLTxB0

LinkedIn, say hello to our Director of Radiopharmaceutical Development, Annukka Perkins! Get to know Annukka: 🧬 Her specialty is radiopharmaceutical chemistry with a synthetic medicinal chemistry twist. 📈 She loves working with different projects and varied radiopharmaceutical applications. She says our clients' success is our success! 🧠 There is no ‘typical’ day for her. Most of her work days involve discussions about scientific capabilities, upcoming projects and building an environment equipped to handle varied requests from clients. 🛠️ She wanted to work for Nucleus because it’s exciting to be part of the next big thing from the very beginning and to build our Rochester R&D laboratory scientific team. #OurNucleus #Community #EmployeeSpotlight #NuclearMedicine #radiopharmaceuticals

WEBINAR: Join us on Thursday, July 18 at 12 pm EST for an insightful discussion featuring Geoff Johnson, MD, PhD! We’ll dive into what Novartis’s pursuit of a label expansion for Pluvicto means for patients and the field of radiopharmaceutical therapy. 🔗 Secure your spot and learn more: https://hubs.ly/Q02FfXhY0

The global radiopharmaceutical market continues to see record growth. Congrats to Radionetics Oncology on their agreement with Eli Lilly and Company!

Introducing the first edition of the Nucleus Nexus Newsletter! Exciting news: We’ve appointed top industry experts to our Scientific Advisory Board. Plus, get our comprehensive intro to #radiopharmaceuticals and check out our new website.

It is an exciting time here at Nucleus RadioPharma as we continue to grow our amazing team! If you, or anyone you know, is interested in joining please go to nucleusrad.com/careers and apply!